# Catalyst Pharmaceuticals (CPRXEUR): who owns it

1 value investor held Catalyst Pharmaceuticals in their Q3 2026 13F, led by Third Avenue Management.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Third Avenue Management | 1.1% | $6.6m | Unchanged | 2 |
| Fundsmith | 0.0% | $0k | Sold out | 5 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/cprx). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.